Validation of a blood protein signature for non-small cell lung cancer

BACKGROUND: CT screening for lung cancer is effective in reducing mortality, but there are areas of concern, including a positive predictive value of 4% and development of interval cancers. A blood test that could manage these limitations would be useful, but development of such tests has been impai...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehan, Michael R, Williams, Stephen A, Siegfried, Jill M, Bigbee, William L, Weissfeld, Joel L, Wilson, David O, Pass, Harvey I, Rom, William N, Muley, Thomas, Meister, Michael, Franklin, Wilbur, Miller, York E, Brody, Edward N, Ostroff, Rachel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123246/
https://www.ncbi.nlm.nih.gov/pubmed/25114662
http://dx.doi.org/10.1186/1559-0275-11-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123246/
https://www.ncbi.nlm.nih.gov/pubmed/25114662
http://dx.doi.org/10.1186/1559-0275-11-32

Ejemplares similares